Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?

References

• McIntosh EDG, Conway P, Willingham J, Hollingsworth R, Lloyd A. Pneumococcal pneumonia in the UK—how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV). Vaccine [Internet] 2005 [cited 2016 Nov 8]; 23(14):1739-45. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0264410X04007315; http://dx.doi.org/10.1016/j.vaccine.2004.08.051
   PubMed Web of Science ®Google Scholar
• Knol MJ, Wagenvoort GHJ, Sanders EAM, Elberse K, Vlaminckx BJ, de Melker HE, van der Ende A. Invasive pneumococcal disease 3 years after introduction of 10-valent pneumococcal conjugate vaccine, the Netherlands. Emerg Infect Dis [Internet] 2015 [cited 2015 Oct 27]; 21(11):2040-4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26488415; http://dx.doi.org/10.3201/eid2111.140780
   PubMed Web of Science ®Google Scholar
• Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease–United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005; 54(1545–861X (Electronic)):893-7.
   PubMedGoogle Scholar
• Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, Petit S, Zansky SM, Harrison LH, Reingold A, et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis 2015; 15(3):301-9; PMID:25656600; http://dx.doi.org/10.1016/S1473-3099(14)71081-3
   PubMed Web of Science ®Google Scholar
• Miller E, Andrews NJ, Waight PA, Slack MPE, George RC. Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine. Vaccine 2011; 29(49):9127-31; PMID:21983361; http://dx.doi.org/10.1016/j.vaccine.2011.09.112
   PubMed Web of Science ®Google Scholar
• Steens A, Bergsaker MAR, Aaberge IS, Rønning K, Vestrheim DF. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Vaccine 2013; 31(52):6232-8; PMID:24176490; http://dx.doi.org/10.1016/j.vaccine.2013.10.032
   PubMed Web of Science ®Google Scholar
• Harboe ZB, Dalby T, Weinberger DM, Benfield T, Mølbak K, Slotved HC, Suppli CH, Konradsen HB, Valentiner-Branth P. Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality. Clin Infect Dis 2014; 59(8):1066-73; PMID:25034421; http://dx.doi.org/10.1093/cid/ciu524
   PubMed Web of Science ®Google Scholar
• Regev-Yochay G, Paran Y, Bishara J, Oren I, Chowers M, Tziba Y, Istomin V, Weinberger M, Miron D, Temper V, et al. Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study. Vaccine 2015; 33(9):1135-42; PMID:25613717; http://dx.doi.org/10.1016/j.vaccine.2015.01.030
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Welfare Finland. Incidence of invasive pneumococcal disease in Finland [Internet]. 2014. Available from: https://www.thl.fi/en/web/thlfi-en/topics/information-packages/incidence-of-invasive-pneumococcal-disease-in-finland.
   Google Scholar
• Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007; 369(9568):1179-86; PMID:17416262; http://dx.doi.org/10.1016/S0140-6736(07)60564-9
   PubMed Web of Science ®Google Scholar
• Nelson JC, Jackson M, Yu O, Whitney CG, Bounds L, Bittner R, Zavitkovsky A, Jackson LA. Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults. Vaccine 2008; 26(38):4947-54; PMID:18662735; http://dx.doi.org/10.1016/j.vaccine.2008.07.016
   PubMed Web of Science ®Google Scholar
• Simonsen L, Taylor RJ, Schuck-Paim C, Lustig R, Haber M, Klugman KP. Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis. Lancet Respir Med [Internet] 2014 [cited 2015 Jan 5]; 2(5):387-94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24815804; http://dx.doi.org/10.1016/S2213-2600(14)70032-3
   PubMed Web of Science ®Google Scholar
• Smith KJ, Wateska AR, Nowalk MP, Raymund M, Nuorti JP, Zimmerman RK. Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine. JAMA 2012; 307(1538–3598 (Electronic)):804-12; PMID:22357831
   PubMed Web of Science ®Google Scholar
• Said MA, Johnson HL, Nonyane BAS, Deloria-Knoll M, O'Brien KL, Andreo F, Andreo F, Beovic B, Blanco S, Boersma WG. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One [Internet] 2013 [cited 2014 Nov 27]; 8(4):e60273. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3615022&tool=pmcentrez&rendertype=abstract; http://dx.doi.org/10.1371/journal.pone.0060273
   PubMed Web of Science ®Google Scholar
• Mangen M-JJ, Rozenbaum MH, Huijts SM, van Werkhoven CH, Postma DF, Atwood M, van Deursen AM, van der Ende A, Grobbee DE, Sanders EA. Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands. Eur Respir J [Internet] 2015 [cited 2015 Jul 21]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/26160871.
   PubMed Web of Science ®Google Scholar
• Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern G V. Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.). Emerg Infect Dis [Internet] 2013 [cited 2016 Oct 14]; 19(7):1074-83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23763847; http://dx.doi.org/10.3201/eid1907.121830
   PubMed Web of Science ®Google Scholar
• van Hoek AJ, Sheppard CL, Andrews NJ, Waight PA, Slack MPE, Harrison TG, Ladhani SN, Miller E. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England. Vaccine [Internet] 2014 [cited 2015 Mar 2]; 32(34):4349-55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24657717; http://dx.doi.org/10.1016/j.vaccine.2014.03.017
   PubMed Web of Science ®Google Scholar
• Mendes RE, Hollingsworth RC, Costello A, Jones RN, Isturiz RE, Hewlett D, Farrell DJ. Non-invasive Streptococcus pneumoniae serotypes recovered from hospitalized adult patients in the United States (2009-2012). Antimicrob Agents Chemother 2015;59(9):5595-601; http://dx.doi.org/10.1128/AAC.00182-15
   Web of Science ®Google Scholar
• Huijts SM, Pride MW, Vos JMI, Jansen KU, Webber C, Gruber W, Boersma WG, Snijders D, Kluytmans JA, van der Lee I, et al. Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia. Eur Respir J [Internet] 2013 [cited 2014 Oct 7]; 42(5):1283-90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23397295; http://dx.doi.org/10.1183/09031936.00137412
   PubMed Web of Science ®Google Scholar
• Sheppard CL, Harrison TG, Smith MD, George RC. Development of a sensitive, multiplexed immunoassay using xMAP beads for detection of serotype-specific streptococcus pneumoniae antigen in urine samples. J Med Microbiol 2011;60(Pt 1):49-55; http://dx.doi.org/10.1099/jmm.0.023150-0
   Web of Science ®Google Scholar
• Rodrigo C, Bewick T, Sheppard C, Greenwood S, Macgregor V, Trotter C, Slack M, George R, Lim WS. Pneumococcal serotypes in adult non-invasive and invasive pneumonia in relation to child contact and child vaccination status. Thorax [Internet] 2014 Feb [cited 2014 Sep 25]; 69(2):168-73. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24048505; http://dx.doi.org/10.1136/thoraxjnl-2013-203987
   PubMed Web of Science ®Google Scholar
• Rodrigo C, Bewick T, Sheppard C, Greenwood S, Mckeever TM, Trotter CL, Slack M, George R, Lim WS. Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia. Eur Respir J [Internet] 2015 [cited 2015 Mar 23]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/25792633.
   PubMed Web of Science ®Google Scholar
• Pletz MW, Ewig S, Rohde G, Schuette H, Rupp J, Welte T, Suttorp N, Forstner C; CAPNETZ Study Group. Impact of pneumococcal vaccination in children on serotype distribution in adult community-acquired pneumonia using the serotype-specific multiplex urinary antigen detection assay. Vaccine 2016; 34(20):2342-8; PMID:27016653; http://dx.doi.org/10.1016/j.vaccine.2016.03.052
   PubMed Web of Science ®Google Scholar
• van Werkhoven CH, Hollingsworth RC, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Sanders EA, Bonten MJ. Pneumococcal conjugate vaccine herd effects on non-invasive pneumococcal pneumonia in elderly. Vaccine 2016; 34(28):3275-82; PMID:27171754; http://dx.doi.org/10.1016/j.vaccine.2016.05.002
   PubMed Web of Science ®Google Scholar